PP

Priyanka Paresh Zope

Active Director Additional Director DIN 11495157
DIN 11495157 First appointment Jan 2026 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Priyanka Paresh Zope

Data last updated:

Priyanka Paresh Zope is an Additional Director at Medixheal Healthcare Private Limited (since 2026). The company operates in Paper.

DIN 11495157
Primary Designation Additional Director
Industry Paper
First Appointment 20 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medixheal Healthcare Private Limited U21004PN2023PTC225313
Additional Director20 Jan 2026Active

Board colleagues of Priyanka Paresh Zope

NameDINCompanyDesignation
Vishal Gajanan Patil10375406Medixheal Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medixheal Healthcare Private Limited
Premium access

Shareholding and investment profile for Priyanka Paresh Zope

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priyanka Paresh Zope

Priyanka Paresh Zope currently holds 1 directorship: Medixheal Healthcare Private Limited (Additional Director, since 20 Jan 2026).

Priyanka Paresh Zope was first appointed on 20 Jan 2026 as Additional Director at Medixheal Healthcare Private Limited.

The current boards of Priyanka Paresh Zope's companies include Vishal Gajanan Patil (Medixheal Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available